BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 31214924)

  • 1. The Relationship Between Neuroimmunity and Bipolar Disorder: Mechanism and Translational Application.
    Niu Z; Yang L; Wu X; Zhu Y; Chen J; Fang Y
    Neurosci Bull; 2019 Aug; 35(4):595-607. PubMed ID: 31214924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neural immune pathways and their connection to inflammatory diseases.
    Eskandari F; Webster JI; Sternberg EM
    Arthritis Res Ther; 2003; 5(6):251-65. PubMed ID: 14680500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytokines and the nervous system: the relationship between seizures and epilepsy].
    Velasco-Ramirez SF; Rosales-Rivera LY; Ramirez-Anguiano AC; Bitzer-Quintero OK
    Rev Neurol; 2013 Aug; 57(4):171-7. PubMed ID: 23884872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors.
    Berk M; Kapczinski F; Andreazza AC; Dean OM; Giorlando F; Maes M; Yücel M; Gama CS; Dodd S; Dean B; Magalhães PV; Amminger P; McGorry P; Malhi GS
    Neurosci Biobehav Rev; 2011 Jan; 35(3):804-17. PubMed ID: 20934453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glial pathology in bipolar disorder: potential therapeutic implications.
    Dong XH; Zhen XC
    CNS Neurosci Ther; 2015 May; 21(5):393-7. PubMed ID: 25753128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential neuroendocrine and immune responses to acute psychosocial stress in women with type 1 bipolar disorder.
    Wieck A; Grassi-Oliveira R; do Prado CH; Rizzo LB; de Oliveira AS; Kommers-Molina J; Viola TW; Teixeira AL; Bauer ME
    Brain Behav Immun; 2013 Nov; 34():47-55. PubMed ID: 23876746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glial cells as key elements in the pathophysiology and treatment of bipolar disorder.
    Keshavarz M
    Acta Neuropsychiatr; 2017 Jun; 29(3):140-152. PubMed ID: 27772534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postmortem evidence of brain inflammatory markers in bipolar disorder: a systematic review.
    Giridharan VV; Sayana P; Pinjari OF; Ahmad N; da Rosa MI; Quevedo J; Barichello T
    Mol Psychiatry; 2020 Jan; 25(1):94-113. PubMed ID: 31249382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of pro-inflammatory cytokines in neuroinflammation, neurogenesis and the neuroendocrine system in major depression.
    Kim YK; Na KS; Myint AM; Leonard BE
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():277-84. PubMed ID: 26111720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroimmune Cross Talk in the Gut. Neuroendocrine and neuroimmune pathways contribute to the pathophysiology of irritable bowel syndrome.
    O'Malley D
    Am J Physiol Gastrointest Liver Physiol; 2016 Nov; 311(5):G934-G941. PubMed ID: 27742703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory mediators of cognitive impairment in bipolar disorder.
    Bauer IE; Pascoe MC; Wollenhaupt-Aguiar B; Kapczinski F; Soares JC
    J Psychiatr Res; 2014 Sep; 56():18-27. PubMed ID: 24862657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine-immune interactions.
    Reichlin S
    N Engl J Med; 1993 Oct; 329(17):1246-53. PubMed ID: 8105378
    [No Abstract]   [Full Text] [Related]  

  • 13. Biological hypotheses and biomarkers of bipolar disorder.
    Sigitova E; Fišar Z; Hroudová J; Cikánková T; Raboch J
    Psychiatry Clin Neurosci; 2017 Feb; 71(2):77-103. PubMed ID: 27800654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review of evidence for the role of inflammatory biomarkers in bipolar patients.
    Sayana P; Colpo GD; Simões LR; Giridharan VV; Teixeira AL; Quevedo J; Barichello T
    J Psychiatr Res; 2017 Sep; 92():160-182. PubMed ID: 28458141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the immune system in the treatment of bipolar disorder.
    Rosenblat JD
    Psychopharmacology (Berl); 2019 Oct; 236(10):2909-2921. PubMed ID: 30756134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF-alpha as a molecular target in bipolar disorder.
    Brietzke E; Kapczinski F
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1355-61. PubMed ID: 18316149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revisiting inflammation in bipolar disorder.
    Fries GR; Walss-Bass C; Bauer ME; Teixeira AL
    Pharmacol Biochem Behav; 2019 Feb; 177():12-19. PubMed ID: 30586559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory Markers in the Staging of Bipolar Disorder: A Systematic Review of the Literature.
    Castaño-Ramírez OM; Sepúlveda-Arias JC; Duica K; Díaz Zuluaga AM; Vargas C; López-Jaramillo C
    Rev Colomb Psiquiatr (Engl Ed); 2018; 47(2):119-128. PubMed ID: 29754705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The local immunoneuroendocrine system of the pancreas and the development of type-1 diabetes mellitus. A hypothesis].
    Goranov VA; Murzënok PP
    Usp Fiziol Nauk; 1997; 28(4):105-16. PubMed ID: 9472156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine abnormalities associated with untreated first episode patients with major depressive disorder and bipolar disorder.
    Feng G; Kang C; Yuan J; Zhang Y; Wei Y; Xu L; Zhou F; Fan X; Yang J
    Psychoneuroendocrinology; 2019 Sep; 107():119-123. PubMed ID: 31125758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.